Did you see yesterday's major news release on GNPX? If you didn't, read it now: Genprex and University of Pittsburgh Sign Exclusive License

StockWireNews

GNPX Morning Update - Major News Yesterday Plus New Stock Profile Arrives 4:00PM EST Today Or 9:30AM Tomorrow

Join My Quick SMS Update System - Sign Up Info Below

February 12th

Good Morning,

Did you see yesterday's major news release on GNPX? If you didn't, read it now:

Genprex and University of Pittsburgh Sign Exclusive License Agreement for Potentially Curative Gene Therapy Candidate for Diabetes

  • Company licenses patented diabetes gene therapy technology designed by researchers at the University of Pittsburgh
  • Results from in vivo animal studies indicate that normal glucose levels in the blood may be restored for an extended period of time
  • Company plans to partner for the clinical development and commercialization of this therapy in the U.S. and internationally

AUSTIN, Texas & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and other serious diseases, today announced that it signed an exclusive license agreement with the University of Pittsburgh for a diabetes gene therapy that may have the potential to cure Type 1 and Type 2 diabetes, which together currently affect approximately 30.3 million people in the U.S, or 9 percent of the U.S. population.

Read the full press release here.

But, that's not all...

I've uncovered a new profile out of the lucrative beverage industry. This low float stock idea could be a major breakout candidate because of 4 key catalysts I've uncovered.

I'm delivering your full report at 4:00PM EST today or 9:30AM Thursday. Clear your schedule now.

Also, if you want to make sure you get this stock profile as quickly as possible, take care of these simple steps:

image

I'll be back to you soon with your full report.

Sincerely,

Kai Parker

StockWireNews


(Always Remember The Stock Prices Could Be Significantly Lower Now From The Dates I Provided.)

Disclosure: I am not a lice.nsed finan.cial adviser. All potential percentage gains are based on from the low to the high of day. StockWireNews full disclosure is to be read and fully understood before using StockWireNews website, or joining StockWireNews' email or text list. By viewing StockWireNews website and/or reading Stock Wire News email or text newsletter you are agreeing to StockWireNews full disclosure which can be read at www.stockwirenews.net/disclosure Make sure to always do your own research and due diligence on any day and swing profile I bring to your attention. Stock Wire News (stock wire news . com) is owned by Stock News Wire LLC, a limited liability company. A member of Stock News Wire, LLC owns an interest in the limited liability company that owns and operates small cap firm . com ("SCF") and an interest in the limited liability company that owns and operates fierce analyst . com ("FI"). From time to time, non-affiliated third parties hire Stock Wire News, SCF and/or FI jointly to publicly disseminate information about a company via website, email, SMS and other points of media. Pursuant to an agreement between StockWireNews LLC and Venado Media, LLC (a non affiliated 3rd party), StockWireNews has been hired for a one day period on 1/21/20 to publicly disseminate information about (GNPX) via Website, Email and SMS. We have been paid twenty-two thousand five hundred USD via bank wire transfer. We own zero shares of (GNPX). Pursuant to an agreement between StockWireNews LLC and Venado Media, LLC (a non affiliated 3rd party), StockWireNews has been hired for a one day period on 2/11/20 to publicly disseminate information about (GNPX) via Website, Email and SMS. We have been paid forty-six thousand USD via bank wire transfer. We own zero shares of (GNPX). To date, we have now been compensated a total of sixty-eight thousand five hundred USD to disseminate information about (GNPX).